![A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes Zoster | NEJM A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes Zoster | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1994/nejm_1994.330.issue-13/nejm199403313301304/production/images/img_medium/nejm199403313301304_t1.jpeg)
A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes Zoster | NEJM
![PDF] Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients | Semantic Scholar PDF] Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a25191f7d00e66b79e17e2b995785cd234a42b21/3-Table2-1.png)
PDF] Low-Dose Acyclovir Prophylaxis for Varicella zoster Reactivation in Autologous Hematopoietic Cell Transplantation Recipients | Semantic Scholar
![Comparison of aciclovir, famciclovir and valaciclovir for management of herpes simplex and herpes zoster infections | Semantic Scholar Comparison of aciclovir, famciclovir and valaciclovir for management of herpes simplex and herpes zoster infections | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ee4838eeadc024a4283a7294d32229e2c0497665/2-Table1-1.png)
Comparison of aciclovir, famciclovir and valaciclovir for management of herpes simplex and herpes zoster infections | Semantic Scholar
![Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation Management of Acyclovir-Resistant Herpes Simplex Virus Infection in Patients Undergoing Hematopoietic Stem-Cell Transplantation](https://jhoponline.com/images/jhop/2021/August/Management_table.jpg)